Barret O - Search Results

1

¹⁸F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy.

Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, Song M, Palleis C, Katzdobler S, Fietzek UM, Respondek G, Scheifele M, Nitschmann A, Zach C, Barret O, Madonia J, Russell D, Stephens AW, Koglin N, Roeber S, Herms J, Bötzel K, Bartenstein P, Levin J, Seibyl JP, Höglinger G, Classen J, Sabri O; German Imaging Initiative for Tauopathies (GII4T). Messerschmidt K, et al. Among authors: barret o. J Nucl Med. 2022 Nov;63(11):1754-1760. doi: 10.2967/jnumed.121.262854. Epub 2022 Apr 14. J Nucl Med. 2022. PMID: 35422444 Free PMC article.

2

In vivo evaluation of [¹²³I]mZIENT as a SPECT radioligand for the serotonin transporter.

Batis J, Barret O, Alagille D, Koren AO, Stehouwer JS, Cosgrove K, Goodman M, Seibyl J, Tamagnan G. Batis J, et al. Among authors: barret o. Nucl Med Biol. 2012 Nov;39(8):1137-41. doi: 10.1016/j.nucmedbio.2012.07.006. Nucl Med Biol. 2012. PMID: 23084043

3

In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.

Tavares AA, Batis J, Barret O, Alagille D, Vala C, Kudej G, Koren A, Cosgrove KP, Nice K, Kordower JH, Seibyl J, Tamagnan GD. Tavares AA, et al. Among authors: barret o. Nucl Med Biol. 2013 Apr;40(3):403-9. doi: 10.1016/j.nucmedbio.2012.12.005. Epub 2013 Jan 16. Nucl Med Biol. 2013. PMID: 23332393

4

Kinetic modeling, test-retest, and dosimetry of 123I-MNI-420 in humans.

Tavares AA, Batis JC, Papin C, Jennings D, Alagille D, Russell DS, Vala C, Lee H, Baldwin RM, Zubal IG, Marek KL, Seibyl JP, Barret O, Tamagnan GD. Tavares AA, et al. Among authors: barret o. J Nucl Med. 2013 Oct;54(10):1760-7. doi: 10.2967/jnumed.113.119933. Epub 2013 Aug 22. J Nucl Med. 2013. PMID: 23970369 Free article. Clinical Trial.

5

Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699.

Caillé F, Morley TJ, Tavares AA, Papin C, Twardy NM, Alagille D, Lee HS, Baldwin RM, Seibyl JP, Barret O, Tamagnan GD. Caillé F, et al. Among authors: barret o. Bioorg Med Chem Lett. 2013 Dec 1;23(23):6243-7. doi: 10.1016/j.bmcl.2013.09.097. Epub 2013 Oct 9. Bioorg Med Chem Lett. 2013. PMID: 24157369

6

Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698.

Tavares AA, Caillé F, Barret O, Papin C, Lee H, Morley TJ, Fowles K, Holden D, Seibyl JP, Alagille D, Tamagnan GD. Tavares AA, et al. Among authors: barret o. Nucl Med Biol. 2014 May-Jun;41(5):432-9. doi: 10.1016/j.nucmedbio.2014.02.005. Epub 2014 Feb 28. Nucl Med Biol. 2014. PMID: 24674817

7

In vivo evaluation of 18F-MNI698: an 18F-labeled radiotracer for imaging of serotonin 4 receptors in brain.

Tavares AA, Caillé F, Barret O, Papin C, Lee H, Morley TJ, Fowles K, Holden D, Seibyl JP, Alagille D, Tamagnan GD. Tavares AA, et al. Among authors: barret o. J Nucl Med. 2014 May;55(5):858-64. doi: 10.2967/jnumed.113.132712. Epub 2014 Mar 31. J Nucl Med. 2014. PMID: 24686782 Free article.

8

In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.

Barret O, Thomae D, Tavares A, Alagille D, Papin C, Waterhouse R, McCarthy T, Jennings D, Marek K, Russell D, Seibyl J, Tamagnan G. Barret O, et al. J Nucl Med. 2014 Aug;55(8):1297-304. doi: 10.2967/jnumed.113.122895. Epub 2014 Jun 4. J Nucl Med. 2014. PMID: 24898025 Free article.

9

Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.

Barret O, Hannestad J, Alagille D, Vala C, Tavares A, Papin C, Morley T, Fowles K, Lee H, Seibyl J, Tytgat D, Laruelle M, Tamagnan G. Barret O, et al. J Nucl Med. 2014 Oct;55(10):1712-8. doi: 10.2967/jnumed.114.142067. Epub 2014 Jul 31. J Nucl Med. 2014. PMID: 25082853 Free article.

10

The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.

Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, Alagille D, Morley TJ, Papin C, Papapetropoulos S, Waterhouse RN, Seibyl JP, Marek KL. Russell DS, et al. Among authors: barret o. JAMA Neurol. 2014 Dec;71(12):1520-8. doi: 10.1001/jamaneurol.2014.1954. JAMA Neurol. 2014. PMID: 25322077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page